The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Medivation Inc

Nasdaq: MDVN
Last

(U.S.) $128.33

Today's change0.00 0.00%
Updated June 1 4:00 PM EDT. Delayed by at least 15 minutes.
 

Medivation Inc

Nasdaq: MDVN
Last

(U.S.) $128.33

Today's change0.00 0.00%
Updated June 1 4:00 PM EDT. Delayed by at least 15 minutes.

Medivation Inc closed at (U.S.)$128.33.

Shares have lost 0.42% over the last five days, but have gained 28.83% over the last year to date. This security has outperformed the S&P 500 by 66.42% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $128.33
  • High--
  • Low--
  • Bid / Ask(U.S.) $128.00 / (U.S.) $134.25
  • YTD % change+28.83%
  • Volume0
  • Average volume (10-day)812,157
  • Average volume (1-month)927,908
  • Average volume (3-month)945,015
  • 52-week range(U.S.) $69.11 to (U.S.) $141.58
  • Beta0.90
  • Trailing P/E37.36×
  • P/E 1 year forward47.77×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.44
Updated June 1 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+38.14%

Based on its net profit margin of 38.14%, Medivation Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue129275200148
Total other revenue--------
Total revenue129275200148
Gross profit--------
Total cost of revenue--------
Total operating expense12913110993
Selling / general / administrative84736353
Research & development45584540
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income11439255
Interest income (expense), net non-operating-6-6-6-5
Gain (loss) on sale of assets--------
Other--------
Income before tax-51388650
Income after tax-31647848
Income tax, total-2-2682
Net income-31647848
Total adjustments to net income--------
Net income before extra. items-31647848
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-31647848
Inc. avail. to common incl. extra. items-31647848
Diluted net income-31647848
Dilution adjustment--000
Diluted weighted average shares78868180
Diluted EPS excluding extraordinary itemsvalue per share-0.041.910.960.60
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.041.910.960.60